CAS 1398583-31-7

3-[[[(1R)-1-(4-Fluorophenyl)ethyl](3-quinolinylcarbonyl)amino]methyl]benzoicacid

CAS : 1398583-31-7

Formule : C₂₆H₂₁FN₂O₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 428.4549

Ref: IN-DA01ENKI

PF-05105679

CAS : 1398583-31-7

PF-05105679

Formule : C₂₆H₂₁FN₂O₃

Degré de pureté : ≥98%

Masse moléculaire : 428.45

Ref: 54-BUP12884

PF 05105679

CAS : 1398583-31-7

PF 05105679 is an investigational pharmaceutical compound developed by Pfizer, classified as a selective nicotinic acetylcholine receptor (nAChR) antagonist. It is synthesized through meticulous organic chemistry techniques, representing a targeted approach to modifying neural pathways. The compound functions by selectively inhibiting specific subtypes of nAChRs, which are ligand-gated ion channels integral to synaptic transmission and neurophysiological processes.

Formule : C₂₆H₂₁FN₂O₃

Degré de pureté : Min. 95%

Masse moléculaire : 428.45 g/mol

Ref: 3D-YFC58331

PF-05105679

CAS : 1398583-31-7

PF-05105679 is a selective TRPM8 antagonist (IC50 = 103 nM). PF-05105679 can be used in research on cold-related pain.

Formule : C₂₆H₂₁FN₂O₃

Degré de pureté : 99.84%

Couleur et forme : Solid

Masse moléculaire : 428.45

Ref: TM-T16483